<SEC-DOCUMENT>0000771856-25-000022.txt : 20250915
<SEC-HEADER>0000771856-25-000022.hdr.sgml : 20250915
<ACCEPTANCE-DATETIME>20250915164722
ACCESSION NUMBER:		0000771856-25-000022
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250915
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250915
DATE AS OF CHANGE:		20250915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS ONCOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11504
		FILM NUMBER:		251314846

	BUSINESS ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205
		BUSINESS PHONE:		410-369-0365

	MAIL ADDRESS:	
		STREET 1:		855 N. WOLFE STREET
		STREET 2:		SUITE 619
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS BIOTECHNOLOGY, INC.
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>csbr-20250915.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a80702f7-6271-42d4-b2ad-cacb9aaa0309,g:beb6d554-1b16-4ad2-9a18-de39639ddb63,d:6581f22aafb7489fae4866fa636e8a6b-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>csbr-20250915</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-18">0000771856</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-19">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="csbr-20250915.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000771856</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-15</xbrli:startDate><xbrli:endDate>2025-09-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6581f22aafb7489fae4866fa636e8a6b_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">September 15, 2025</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CHAMPIONS ONCOLOGY, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:30.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.674%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-11504</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">52-1401755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1 University Plaza, Suite 307</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Hackensack</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">New Jersey</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">07601</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">201</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">808-8400</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address if Changed Since Last Report)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:484.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:484.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:484.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:484.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act </span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.935%"><tr><td style="width:1.0%"/><td style="width:41.182%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.735%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock, par value $0.001 per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">CSBR</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The Nasdaq Stock Market LLC</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-17">o</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION TO BE INCLUDED IN THE REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:266.25pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:205.75pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.02.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations and Financial Condition.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 15, 2025, Champions Oncology, Inc. (the &#8220;Company&#8221;) issued a press release regarding the Company&#8217;s unaudited financial results for its first quarter ended July 31, 2025. A copy of the Company&#8217;s press release is attached hereto as Exhibit 99.1.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information contained under Item 2.02 in this Current Report shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:213.75pt"><tr><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:46.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:153.25pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="padding-left:9pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibit is filed herewith:</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit No.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:207.00pt"><tr><td style="width:1.0pt"/><td style="width:22.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:181.00pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k7312025ex991xq126.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k7312025ex991xq126.htm">Septem</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k7312025ex991xq126.htm">ber</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k7312025ex991xq126.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k7312025ex991xq126.htm">15</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="csbr8-k7312025ex991xq126.htm">, 2025</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.351%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CHAMPIONS ONCOLOGY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date: September&#160;15, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert Brainin</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Robert Brainin</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>csbr8-k7312025ex991xq126.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i860e44122aeb4d7aa44d1d7c51e620f9_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><img alt="logobranding_headerleftalia.jpg" src="logobranding_headerleftalia.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:666px"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        NEWS</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">One University Plaza, Suite 307 Hackensack, NJ 07601 Tel&#58; 551-206-8104</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%;text-decoration:underline">Champions Oncology Reports Quarterly Revenue of $14.0 Million</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:13pt;font-style:italic;font-weight:400;line-height:120%">Positive start to FY 2026 with steady revenue, data growth and new leadership</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:115%">Hackensack, NJ &#8211; September 15</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:115%">, 2025</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:115%"> &#8211; Champions Oncology, Inc. (Nasdaq&#58; CSBR), a leading translational oncology research organization, today announced its financial results for its first quarter of fiscal 2026, ended July 31, 2025.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">First Quarter and Recent Highlights&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Total revenue of $14 million</font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Adjusted EBITDA of $60,000</font></div><div style="padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.3pt">Appointment of Rob Brainin as Chief Executive Officer to lead the next phase of growth</font></div><div style="text-indent:4.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Rob Brainin, newly appointed CEO of Champions, commented, &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">It is great to be joining Champions at such an exciting inflection point. Our core services business&#8212;the backbone of our company&#8212;is strengthening and well positioned for sustained growth. At the same time, we are scaling our emerging data platform, which has already shown encouraging traction with leading biopharma partners. These complementary growth engines give us the opportunity to deepen our scientific impact, deliver innovative solutions to patients and customers, and create durable long-term value for shareholders. In parallel, our Corellia team continues to generate data demonstrating the potential of the compounds in our pipeline. Over the coming quarters, I look forward to working closely with our talented team to sharpen our strategy, invest in key capabilities, and build on Champions&#8217; culture of collaboration and scientific excellence.&#34;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">David Miller, CFO of Champions, added, &#34;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">We opened the fiscal year with $14 million in revenue and adjusted EBITDA of $60,000. While revenue was slightly lower than the first quarter of last year, we achieved solid sequential growth that met our expectations and provides a strong foundation for the year. As we move forward, we anticipate continued topline expansion and margin improvement driven by a healthy services pipeline and growing demand for our proprietary data offerings. Our financial </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">discipline and focus on profitable growth give us the flexibility to invest in strategic initiatives that will position Champions for long-term success.</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">&#34;</font></div><div><font><br></font></div><div><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">First Fiscal Quarter Financial Results</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Total oncology revenue for the first quarter of fiscal 2026 was </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$14.0 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> compared to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$14.1 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> for the same period last year, consisting of a $400,000, or 3% decline in service revenue and a $300,000 increase in data license revenue. Total costs and operating expenses for the first quarter of fiscal 2026 were </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$14.5 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> compared to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$12.7 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> for the first quarter of fiscal 2025, an increase of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$1.8 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> or 14.1%.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">For the first quarter of fiscal 2026, Champions reported a loss from operations of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$527,000</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, including </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$208,000</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> in stock-based compensation, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$358,000</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> in depreciation and amortization expenses, and a $20,000 charge for the disposal of lab equipment, compared to income  from operations of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$1.3 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">inclusive</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$258,000</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> in stock-based compensation and </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$448,500</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> in depreciation and amortization expenses, in the first quarter of fiscal 2025. Adjusted EBITDA, which is defined as income from operations excluding stock-based compensation, depreciation and amortization expenses, and equipment disposal charges, was </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$59,000</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> for the first quarter of fiscal 2026 compared to adjusted EBITDA of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$2.0 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> in the first quarter of fiscal 2025.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Cost of oncology revenue was </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$8.0 million, up</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$923,000</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, or 13.1%, from $7.1 million in the same period last year. The increase primarily reflects higher outsourced lab services for radiolabeling work, which will vary from quarter to quarter. Importantly, as we migrate this work into our own labs in the coming quarters, we anticipate a reduction in cost of sales and improvement in gross margins. Gross margin for the quarter was 43% compared to 50% in the prior year. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Research and development expense for the three-months ended July 31, 2025 was </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$2.1 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, an increase of $628,000 or 43.2%, compared to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$1.5 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> for the three-months ended July 31, 2024. The increase reflected greater investment in sequencing and related costs to develop our data licensing platform. Sales and marketing expense for the three-months ended July 31, 2025 was </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$1.9 million, an increase of $176,000, or </font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">10.5%</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, compared to $1.7 million </font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">for the three-months ended July 31, 2024. The increase was related to compensation expense to support the growth of our data license business. General and administrative expense for the three-months ended July 31, 2025 wa</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">s $2.6 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, an increase of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$43,000</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">, or 1.7%, compared to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">$2.5 million</font><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%"> for the three-months ended July 31, 2024 driven primarily from an increase in IT related costs. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Net cash provided by operating activities was approximately $600,000 for the quarter, supported by receivables conversion and normal working capital activity, partially offset by a quarterly net loss. Net cash used in investing activities for the three-months ended July 31, 2025 was approximately $46,000 for lab and computer equipment.  Net cash used in financing activities for the three-months ended July 31, 2025 was $14,000 resulting from financing lease payments slightly offset by proceeds from options exercises. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Company ended the quarter with cash on hand of approximately 10.3 million and no debt, providing us with a strong balance sheet and financial flexibility. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conference Call Information&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">The Company will host a conference call today at 4&#58;30 p.m. EDT (1&#58;30 p.m. PDT) to discuss its third quarter financial results. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">To participate in the call, please call 888-506-0062 (Domestic) or  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">973-528-0011 (I</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">nternational) and enter the access code 261008, or provide the verbal reference &#34;Champions Oncology&#34;.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Full details of the Company&#8217;s financial results will be available on September 15, 2025 in the Company&#8217;s Form 10-Q at</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#333366;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">www.championsoncology.com</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">* Non-GAAP Financial Information</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains &#8220;Non-GAAP financial measures,&#8221; which are measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">A further explanation and reconciliation of these Non-GAAP financial measures is included below and in the financial tables in this release. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Company believes that the Non-GAAP financial measures presented facilitate an understanding of operating performance and provide a meaningful comparison of its results between periods. The Company&#8217;s management uses Non-GAAP financial measures to, among other things, evaluate its ongoing operations in relation to historical results and for internal planning and forecasting purposes. Adjusted EBITDA and Adjusted EPS represent measures that we believe are customarily used by investors and analysts to evaluate the financial performance of companies in addition to the GAAP measures that we present. Our management also believes that these measures are useful in evaluating our core operating results. However, Adjusted EBITDA and Adjusted EPS are not measures of financial performance under accounting principles generally accepted in the United States of America and should not be considered an alternative to net income, operating income, or EPS as indicators of our operating performance or to net cash provided by operating activities as a measure of our liquidity. We believe the Company&#8217;s Adjusted EBITDA and Adjusted EPS measures provide information that is directly comparable to that provided by other peer companies in our industry, but other companies may calculate Non-GAAP financial results differently, particularly related to nonrecurring, unusual items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Adjusted EBITDA</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Adjusted EBITDA represents net income (loss), or net income (loss) from operations, excluding the effect of stock-based compensation and depreciation and amortization and may also exclude other items not indicative of our ongoing operating performance, when defined.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Adjusted Net Income (Loss) and Adjusted Earnings Per Share (EPS)</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Adjusted net income (loss) (if denoted) and adjusted EPS exclude the effect of stock-based compensation and depreciation and amortization and may also exclude other items not indicative of our ongoing operating performance, when defined.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">About Champions Oncology, Inc.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&#38;D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%"> 99.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:112%">Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Media Inquiries&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Gavin Cooper</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">Vice President, Global Marketing</font></div><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">gcooper&#64;championsoncology.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Website&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">https&#58;&#47;&#47;www.championsoncology.com&#47;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Facebook&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">https&#58;&#47;&#47;www.facebook.com&#47;championsoncology&#47;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">LinkedIn&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">https&#58;&#47;&#47;www.linkedin.com&#47;company&#47;champions-oncology-inc-&#47;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Twitter&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#64;ChampionsOncol1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Instagram&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">https&#58;&#47;&#47;www.instagram.com&#47;championsoncology&#47;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">This press release may contain &#34;forward-looking statements&#34; (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties.  Champions Oncology generally uses words such as &#34;believe,&#34; &#34;may,&#34; &#34;could,&#34; &#34;will,&#34; &#34;intend,&#34; &#34;expect,&#34; &#34;anticipate,&#34; &#34;plan,&#34; and similar expressions to identify forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors.  See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2025 for a discussion of such risks, uncertainties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i860e44122aeb4d7aa44d1d7c51e620f9_4"></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Champions Oncology, Inc.</font></div><div style="text-align:center"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in thousands) </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP Net (Loss) Income to Adjusted EBITDA - (Non-GAAP) (Unaudited) </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.038%"><tr><td style="width:1.0%"></td><td style="width:65.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>July 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income - GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(466)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">448.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss on equipment disposal</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA - Non-GAAP</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of GAAP EPS to Non-GAAP EPS (Unaudited) </font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.839%"><tr><td style="width:1.0%"></td><td style="width:65.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.959%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.176%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>July 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8211; basic, GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock-based compensation on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of depreciation and amortization on EPS</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of loss on equipment disposal on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.001&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EPS - basic, Non-GAAP</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>July 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8211;  diluted, GAAP</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock-based compensation on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of depreciation and amortization on EPS</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Effect of loss on equipment disposal on EPS</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.001&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EPS - diluted, Non-GAAP</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Statements of Operations (unaudited)</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.647%"><tr><td style="width:1.0%"></td><td style="width:67.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.992%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>July 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oncology revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,995&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,061&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of oncology revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,995&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,072&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,570&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,527&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of equipment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) income from operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(527)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,329</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) income before provision for income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(452)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(466)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,313</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; net loss attributable to noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to Company's common shares</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(436)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income  per common share outstanding</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">basic</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">basic</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,788,414&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,593,766&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">and diluted</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,788,414&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,042,379&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:justify"><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.871%"><tr><td style="width:1.0%"></td><td style="width:71.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.413%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">July 31, 2025</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">April 30, 2025</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(unaudited)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,325&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,785&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,474&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,204&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,215&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">21,014</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">22,358</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,771&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other long term assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">30,546</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">32,344</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,804&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,430&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,443&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">22,698</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">23,853</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,244&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,634&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other Non-current Liability</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">27,008</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">28,572</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity attributable to Champions Oncology, Inc.</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,508&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders' equity</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">30,546</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">32,344</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:29.25pt;width:100%"><div><font><br></font></div></div><div><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Statements of Cash Flows (unaudited)</font></div><div><font style="color:#00000a;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>July 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss)  income</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(466)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash provided by operations&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts and estimated credit losses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(29)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(71)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,927)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">600</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">311</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(46)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities&#58;</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(46)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the exercise of stock options</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease payments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(38)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities&#58;</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(14)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(37)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash at beginning of period</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,785&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,618&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash at the end of period</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">10,325</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,892</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>csbr-20250915.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a80702f7-6271-42d4-b2ad-cacb9aaa0309,g:beb6d554-1b16-4ad2-9a18-de39639ddb63-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:csbr="http://championsoncology.com/20250915" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://championsoncology.com/20250915">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20250915_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20250915_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="csbr-20250915_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://championsoncology.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>csbr-20250915_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a80702f7-6271-42d4-b2ad-cacb9aaa0309,g:beb6d554-1b16-4ad2-9a18-de39639ddb63-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://championsoncology.com/role/CoverPage" xlink:type="simple" xlink:href="csbr-20250915.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://championsoncology.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_d516a791-1662-465c-a561-59b37e7f60d0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4710df3c-1bf5-4ff9-830c-c756be8db9b0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_d516a791-1662-465c-a561-59b37e7f60d0" xlink:to="loc_dei_DocumentInformationTable_4710df3c-1bf5-4ff9-830c-c756be8db9b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3ef909e8-72d9-4030-bf41-8e64219e40e7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_d516a791-1662-465c-a561-59b37e7f60d0" xlink:to="loc_dei_DocumentPeriodEndDate_3ef909e8-72d9-4030-bf41-8e64219e40e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>csbr-20250915_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a80702f7-6271-42d4-b2ad-cacb9aaa0309,g:beb6d554-1b16-4ad2-9a18-de39639ddb63-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2bfd0b9b-24ae-40ad-ab30-fbbeaa11cd7b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_66768524-dc02-48f6-b67e-7a9a65a55543_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_13ca6575-6988-45f9-b3c7-b06cbdf48693_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e777ba51-ed34-4da5-ac6b-09c05f9bcbc5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_30289ed1-eba7-4080-bf50-abbf9368a54f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_4d37877e-8bce-4605-ad37-60476a24c9d2_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_2bb28930-9838-45f8-a19c-9bc9a95a62b8_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3d509b88-c5e9-4c1d-b9b7-b853d749ee3b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1f552992-f4f9-467d-bf34-4cead83efbe4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_e286e8f2-7db2-4eb3-b614-2bf356b0e8c2_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4cdaf854-a392-47e5-83d9-f239be199625_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_998552bf-c037-4a49-8c21-0d225e2c1464_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_004d20cc-3c46-4e4a-a2c7-78a846b5bd57_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5168224f-4b58-45c0-927b-f7021e61b4be_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f2da06c5-4cd8-4f15-a94b-5994f500aa19_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_31cb1677-bd17-4744-85c4-d4496b7998bc_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6171cac5-a4b1-44b7-ad47-047c629e9e27_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_fd33f396-da62-48e1-ba9e-9c9827c5228d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_137b4c53-aac7-43e6-a729-41361be4b5ee_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8465fcfe-5a51-49d9-82eb-0308ccbffb08_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_03b60d34-e35a-40b1-b709-7a35ed34c772_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>csbr-20250915_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a80702f7-6271-42d4-b2ad-cacb9aaa0309,g:beb6d554-1b16-4ad2-9a18-de39639ddb63-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://championsoncology.com/role/CoverPage" xlink:type="simple" xlink:href="csbr-20250915.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://championsoncology.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d9f328c7-ea37-4bf0-bf25-20de6783891b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_DocumentType_d9f328c7-ea37-4bf0-bf25-20de6783891b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_bc6ed3c9-eb49-4c1b-afa3-c31ae1c4ece3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_DocumentPeriodEndDate_bc6ed3c9-eb49-4c1b-afa3-c31ae1c4ece3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_358b99ec-015f-4a9e-82a6-c1d2dd37b945" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityRegistrantName_358b99ec-015f-4a9e-82a6-c1d2dd37b945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1c9cfa51-912b-4dec-a9e9-ea951b768480" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1c9cfa51-912b-4dec-a9e9-ea951b768480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4309922b-e9c0-475e-8c26-b42a234d4b7e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityFileNumber_4309922b-e9c0-475e-8c26-b42a234d4b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d2d621bb-a2e1-44c7-b055-ff37a5c9704e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityTaxIdentificationNumber_d2d621bb-a2e1-44c7-b055-ff37a5c9704e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_fe329344-e49a-400b-9f6d-20f355943934" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityAddressAddressLine1_fe329344-e49a-400b-9f6d-20f355943934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_07693298-9020-4b98-904e-404fcc72ea53" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityAddressCityOrTown_07693298-9020-4b98-904e-404fcc72ea53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_44e658d1-7aec-41d9-9496-68307ca1a8d8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityAddressStateOrProvince_44e658d1-7aec-41d9-9496-68307ca1a8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7e730f42-b0e6-458b-aeb6-d90f563e0da7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityAddressPostalZipCode_7e730f42-b0e6-458b-aeb6-d90f563e0da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_260dbbde-76ae-4e75-ab12-523d9452beca" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_CityAreaCode_260dbbde-76ae-4e75-ab12-523d9452beca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_111da33f-6ab4-4a09-9d86-3c468b0632e7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_LocalPhoneNumber_111da33f-6ab4-4a09-9d86-3c468b0632e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_c2e76b9c-e5c6-477d-a2eb-6fa388d05377" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_WrittenCommunications_c2e76b9c-e5c6-477d-a2eb-6fa388d05377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_94fc0fd7-87ec-4ff1-9552-5a6a4b347b44" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_SolicitingMaterial_94fc0fd7-87ec-4ff1-9552-5a6a4b347b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6bf5d018-a1f2-46a1-98bc-1500d36ccfce" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_PreCommencementTenderOffer_6bf5d018-a1f2-46a1-98bc-1500d36ccfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_ebb86699-a2eb-4c60-8ef2-48d299a53fd4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_ebb86699-a2eb-4c60-8ef2-48d299a53fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ce200e2b-c82b-4298-aaa6-8d92e56a56b7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityEmergingGrowthCompany_ce200e2b-c82b-4298-aaa6-8d92e56a56b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8a0aee92-3e3a-41fc-a490-5f24f74c3c7b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_EntityCentralIndexKey_8a0aee92-3e3a-41fc-a490-5f24f74c3c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_60120d36-2624-4603-8c42-40bb315713c0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_AmendmentFlag_60120d36-2624-4603-8c42-40bb315713c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4710df3c-1bf5-4ff9-830c-c756be8db9b0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d1e3533f-02f8-4f32-beef-a543ba97cf43" xlink:to="loc_dei_DocumentInformationTable_4710df3c-1bf5-4ff9-830c-c756be8db9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_d516a791-1662-465c-a561-59b37e7f60d0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_4710df3c-1bf5-4ff9-830c-c756be8db9b0" xlink:to="loc_dei_DocumentInformationLineItems_d516a791-1662-465c-a561-59b37e7f60d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3ef909e8-72d9-4030-bf41-8e64219e40e7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_d516a791-1662-465c-a561-59b37e7f60d0" xlink:to="loc_dei_DocumentPeriodEndDate_3ef909e8-72d9-4030-bf41-8e64219e40e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logobranding_headerleftalia.jpg
<TEXT>
begin 644 logobranding_headerleftalia.jpg
M_]C_X0E@17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    A    <@$R  (    4
M    DX=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C$@*$UA8VEN=&]S:"D ,C R,#HP-3HQ-" Q,#HU-SHT,P
M  .@ 0 #     ?__  "@ @ $     0   S2@ P $     0   5X
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   ()@        !(     0   $@
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MJ22GZJ27RJDDI^JDE\JI)*?_V?_M$>Q0:&]T;W-H;W @,RXP #A"24T$)0
M    $                      X0DE-!#H      0L    0     0
M"W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT
M97).86UE5$585    !0 0P!A &X ;P!N "  5 !2 #@ -0 P #  ( !S &4
M<@!I &4 <P      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\
M9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M
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M9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M"G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M    3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M        4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN
M9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,
M969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!2
M96-T5&]P;&]N9P      .$))30/M       0 2P    !  $!+     $  3A"
M24T$)@      #@             _@   .$))300-       $    6CA"24T$
M&0      !    !XX0DE- _,       D           $ .$))32<0       *
M  $          3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8
M 0"AF9H !@       0 R     0!:    !@       0 U     0 M    !@
M     3A"24T#^       <   _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H   X0DE-!
M      ( "SA"24T$ @      &                                #A"
M24T$,       # $! 0$! 0$! 0$! 3A"24T$+0      !@ !    ##A"24T$
M"       $     $   )    "0      X0DE-!!X       0     .$))300:
M      .+    !@             !7@   S0    K $P ;P!G &\ ( !" '(
M80!N &0 :0!N &< 7P!( &4 80!D &4 <@ @ $P 90!F '0 ( !! &P :0!G
M &X 90!D "  =P!I '0 :  @ $< <@!I &0    !
M      $              S0   %>                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     PX0DE-! P     "$(    !    GP
M $0   '@  !_@   ""8 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( $0 GP,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MI>3JS^3_ )Z;PR[+N(=V\DL\=:Q-99<($NBI[@/:VR/4J;94_P!KO\&]^_\
MP:MX][<BH6L:YK73 >TL=II]!\/2((W"@0=BE22202I))))3_]+U5))))2DD
MDDE*3$ B#J"G224I))))2DT"9[ITDE*30)GNG224M ^Y.DDDI22222E))))*
M4DDDDI__T_54E\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27
MRJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?_V3A"24T$(0
M5P    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !0
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M ?_$ 0$  0 " P$! 0             %!P0&" ," 0$!  (# 0
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M$0   .J0
M
M
M
M
M
M
M
M    "/WTU&Q6C=],_3?;J]B3TD
M             &EV:O/G7X]<7*7QG 'UA8E.[T#R>QO56V
M                               !1O4Y7.G8XOGG   'UA?G*Z_0?([(
M                                            %)=/E<U]KB #TQF3
MTWCM]/'. )Z&;L[SGII6.0
M     #59Z_%WI?,>.<"1TWZ*X_:MSG]'*UV\,XJR_P _G'L<7UQGL'SWI-BA
MF                                            '+/=X%2=#G#.TW[
M'\[Z7;*]@ " EA^,MBAF
M    'EG'!WJO)8FVHZ.XW:O/E]8:39JT[T>9LL,]W\SJ^F,@1N^DCIN/C./3
M&?+./7&1B;:Y>NP\<X]L9^,X \F/?&WZ>.<>V,B/WTS==OO&?/./O&1\9QZ8
MSC;:^N,^F,@                           :Q/!Q+Z;RP'<WE_5S<4L/)
M%Q#Z?RV)MJ+^Y/7Z#Y'9^,XY.[WGO3&9/3>[>9U:7Z?+Z(X_:Y6[OG^N?/\
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M_5+%?ZPJ^]0W6M:R]=K6H=#FCM<.SJ5[H#D]C[QD
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M_:J]BQJ=W2[-67CD^F8"6':H+%47^?*1[VG1Z
M      YG[7#I;I\L>^N>N?/^CL&I<  TZS6^&-TK6@  /+.*:Z7,VVO8CM])
M'3?8X9ZEO\ZT:-^L;U&QJ5V/WTWNK;IOH\R<CEEHY-%M5=QK6?S+9X)Y6.0
M                              ""EAXI]+YC!WT'MC-Y\OK6[S^C/0RP
MTL=3W^=0_5Y/MC/7/G_1[O5M  #2[-6#EBTVS5QLXKZW3MWG]&T:-^O;E/<:
MUFK[U#,UVM>AT:QNT(:6+ZQF;CEL&G<H7K<CI_A]X
M             "KKU#E/O>?\\X    S]-^W/,^IEHY  !5-_G[C7L^3&-MKL
MT$]67Z%ETKU;7*-C4[VC6JD]%+#21SD4LAKOH=JI:]#H:U-!M4%@
M                         5A>H<N=S@X&^@  &7KMTOQ>Y;_.Z0
M                                       $-)%1'5Y-37^=#RQ@2D<E
MK4.A?'*ZT_%,                                               !
M"RQ8.VF9KO-Q2_H
M
M                                              ,?.,C&0
M,?.,C&0  //./P]<9 Q\X]\9\,ZY&-@ ,?.,C&0
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MBEV:&8
M
M
M
M
M
M
M
M
M
M
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M%F*WH#0D\9$@I*G*?EYIX@5K)"N@> O ;HCIW)"FG7S<7S"+QIK[ES1/FO\
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M.,BHW\85-.!TEPQC_%QH30L6VNF83;:\7XP.Z_*ATQ#!O3K:&,>&+2DG-&(
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MX=LMZ;;+A8:S@;% F]L%%>?J.R=!K$KC=MM:E<FC[5<,K]&VAIM.<L^ C6'
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MHDB7:2VLD+A=Q7\:SG=KIF;ETBR;;SY=G=V:;<H]]HD"WURO[;.0*U@=H,A
MRF%H,_$7?$;++A[-B:8L&[YC%0LOBJCM_9Z](795(]K8I8AN#*H,]=PL[LY-
MGY =N8XV ]I7UJ]EVSD9&?:H>.W-W!   (VU+D>BKMTPN?O=2:MM5R.V^4RV
M&';V.]9J'M+)J64W!IY6^LV+!KE:SN)]AAF:[6<W>=L$I*+?Z)09]3F9W;Z)
MG[=;:XU11V>D%'MF0V+D28Z4?E?1V:_]!NNVF:M4BR[<R\CGGV&I#%:VQL%;
MD9_:"9D,P.V; Y.-M;&+'X&@9>/@J!M5)J.0HE+&JP_]JG__V@ ( 0("!C\
M_P!;NP.KER*Y6@CC#9=M*W$>%=2>RGOCM<7JIW;/LJH?+^[Q<KE=J\*\?>K.
M Y1ES\6@.1,-+FY-#"/J3DOH<)I8@GBG*<\6ZN66DDW!.;N$X3GBVR ')IH'
M)ILLCM*TE/$NF/ =C["T>VL!]A8%;[ZCU\ GIT"/.F%VD3'>TO+-X4UJJO.J
MH]:&\AUH_#1T1Q(Q3%#K3%4IM8YD-W\9*7P3&];01CS+N>715+-X4U_4MI4E
M2[OF50S!10ZTQN" /THDVM\WOJ/"' /PT13<YTQZTTD]J/PT.=;$I.,V)5<D
MD.M5(2O;*C :H0W?QDI?!.+D7O*)"[GE0!YPBVAN=1/6I=WS(P/=0D,I0ZTY
MN6TG@4WOF)Z> 1TZ 1R)QII%T= ES+H*9D[X@H]:'6AUH_!"*#KE3C>BAUH_
M!&/RH]2&[^,E+X*D )KAV='<\J=;RLQ!.<R8714N[YD2.A=H9D.M=D+#;]*Q
MWJ1'/[Z!Y]-8[VEXEE: F)8=G@85E3&Y"0Y$Q"=4D!. G.BE@G5) T.$Y187
MJHZ:6%U.AXE6@)LHT%AF51500!%R>)8JT IAA]]T[.EBG&7A67+L^P8+'(1*
M?-%5 V[*()I94A-7B5 M*:4\28J,WS:'G*A5 U15E@1IF'"(=BC$V4YD0"XX
MA"00(N.EBG@>ZK8E7*R)3S/=3"Y,;EV>'%T2;CE32O\ ^54.0^9?F1UPCSLF
M(Q(@WLB#>2HB6;_A0^W(HDW5! ZK*5733]MY2$<RI(-:-.K)5 ,?4XB,<I]F
MQN1$34.&Q:2Q*C53!.+U<%43B5P3R0 $;/MSH.UB;,K;D\58P3E")NCQ%8VQ
M3@N/8.;E3'+XN+SQ*QAE87X%I9814GD>,5A/WK,5;(_?_DR86_X)A;[!@F/
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M-RAM/*Z[9(GT]A_%P+,MNQ!8V@M2:O(TH.G=N4-%_P!9PF*EQKU\-=9*^/F
M,E@3,VBM*B;ALDU4;4W<KVG]7J'_  C?UAQE5EC60#'Z@. PUYT?U\9(BM$"
M*LY!"+_9M][C&_NK/]P_&2S3$<ZO$5JJ=#NGD\$0T/?XR"WN;N+QQ9B:2MME
MMSV79%+2L=!N"OJ[;6;C];C_ /3O_P#3XBJY'6")YGQ>50GL7<^S<?1\.95;
M=[&[C)_X2?\ NVXQO[JS_</QC,\[K!"A S<(U#64B&L6T@>8Z<J1B?U7E\2<
M8>.-0D:7PJ(H 55$$@  '<!QD/\ >LW^S5^.G/WMK^K'Q'FLG;OPVGGEB*5I
M(5CVQD =CPR-K^5PEVO5DO78CNAL7G$I0CMU5%6.+=]3<O<OT6?_ #,_^WGB
M:K.N^"=&BE3ZT<%6']!X0J"EK'3\^A.P.R> D@'T;DD36.0#WTX6;)2S8NX%
MUEJO%),-WI"21*P9?J+\O[/$&*Q,4D&#K2<W=* )9Y@"H8J"=J*&;8NOO-ZJ
MK+=R$1AR.9=)Y(6&C) @(A5AZ&\;O[N_;YN.EO\ M_\ X;BG4M1+-6L-;BFA
M<:JZ/,X92/J(X:*,-)A;I:3&6#V^$'Q1.?[2+7\M=K^ZN<_PD7]YQ'+%$MC+
MWBR8^NX/+\&F^20@CP(&'A!W.S?:91#U+$V.G(^/7FA>W78^X8TD)'[R->#/
MT7!R,:8E$^U&AB>?<Q+11, T:;=@TVIXO4]KI^M<#+9CHP[T;L905!52/054
MA?Y9>*1=T;J5=3W$$:$<9'$2Z[Z%F6OJ?2(W*AORAXOIL]'W9-ID9K6++'O;
M3XT0_$.:H_>_2:&:I17:Q.JK(.U6TTW(XT=&]Y&5N#)6O9"K&W[$/$ZC[):/
M=^<S<)<JU'NWHSK%:O,)60CTJH5(E;WN7N^X09FJ?FHEVPWH&Y<Z+KKH&T(9
M>WRR*Z\%DS]E8->R-H$9]/MAE'Z''S6/@>SDM-/XA;(DE4$:$1@!4CU]Q=^W
MPLW%["V9'B@O1F*22/3>H)!U7<"/1Q9R&/NVK,MF#Y=TL<O:%WJ^HV*IUU7B
MQ4<E4L1O$S+W@.I4D:_AX@SE+(7+%BNLB+%-RMA$B%#KM13W'Z^*N/O7K-2K
M6E,YCK;/&^W:I;>K>0%M/M<38_&R2S_,3&>:Q/MYC':%"^$*-J@>'[3?1:SD
M]RU4L6]IFBK\OEEE4)NT9&.K!?%P,5-8DG'RWRLEI].:_P /EF1M!MWMYCV>
M;B#.4LA<L6*ZR(L4W*V$2(4.NU%/<?K^BMC\A9GK15I_F$>OLW%MC)H=ZL--
M&XFQ./L3689[+6FDL;=P9XTC(&P*-ND0XHQ9&U8JK0:1XS7V:L90H.[>K>QP
MF%HSRV($D>423[=^LAU(\(4?3)U,V1NBW)?.2,(Y7+YC3<_;Y-VS=V=_T"EG
M*:V$34P2CPRQ,>\QR#Q+W=H\K>MQNIYRU#!K^KEBCE;3[2F(?H<17]DN4R,)
M#13W"K)&X[FCB4*@([U+\QE;RM]&._B-NQ5_AW.Y7R^SQ<_E[MV]6[N4-.(,
M'2FEL5Z[2.LLVW>3(Y<Z[0H[S]7$V&RJ$PR$/%,F@DBE7RR1D@Z,.[WEW+ZW
M%RWCKEFT]R-8G6QR] %;=J-BKP^.S%..[3?M,4HUT/=N4C1D<:]CH5;AI,;D
M[E%6_9.$G13[NH1]/M.W$5^U)/E[$+!HDL[! K ZAN6H\1'OLR^[_+=;J:O'
MI5RB"&TP[A9A70:_O(0NW]T_TP7:<K06JSK+!,AT9'0ZJP/WCPE:PR5NHJZ#
MYNIKH)0HT,T(]*'UE\T7V=KM]R9;#"QE9E/R..4^-SW;GT\D0]9_S/%QS(MM
M;+UU'S^/)U*GNYD>O:T3'T^KY6][[N:W:D6&M71I9IG.BHB#<S$_4 .)TZ-Z
M3M9FC5;XMO;*Q*]O[.)'Y>[3P;WW>YQ-2^7?&YJLN^:A*P?50=I:-]%W;3IO
M5D1EX@Z;R-$#&NL33Y,2'=&)@=&,>WM56TW>+R_F\8Z_6I1Y)+\K1KK+RU"A
M-X8,JONUXFS.6<K7B(1(T ,DDC>6.-21JQT_-W-Y>&S$/1,[=.J3_KFZ;;M!
M[6,PBY0_Y/M<1]7WUEQV-> 6&CL+ME 8[54+ZQD;3E:?K-R>UQ-D<+T79MX*
MN6YELF5NQ1J2SQQM''IZW;)MX>YCPT%FN0EVE)H7B9M=O:.QD;0['_JMQG^E
MGH+7CPO,VVA(6,G+E6/M3:-NN[7S<$DZ =I)XGQ?1'3T_4)K:\RV@D96"G0L
MD<2.QC]F1F3=[/$F"R-"3"Y^/=MIRDL)-@U=5+*C+(H&YHW3R^UQ$]J-KF1M
M:_)X^,A6<+WL[D'EQCNW;6;=Y4\VVI_'.B+=6A?D6.M*@F5V+G10@EC5)7/J
MINCW<4LK!AQD,=,_+MLTIC>!V[4!"K(NC>(;MWG^UQ2ZEJ 7SE-G\,J[MADU
M[7W$!]G*77F=GZSX?%/(9:DN.NVHQ*U)7,AC5NU Q*H=^W0NNWP-X?YA7<);
M\(L)K!-IJ8IE[8Y!]EO-[2;EXM8K(Q&&[3D,<T9^L=Q!]*L/$K>LOTQ6Z<SU
M[4#!X9HV*NK#N*L.T<1T^KJC60H"C)U HD/HUEA.U6^^T;+^[X4T\_4#-W16
M'^6D_!LFY;'\7!E&0K&('0R<Z/:#]6NNG#->SU-637=%%*LTO9_S<6]_T>)*
MG2%-C(>S^)W%  ^_'#J=?O-*?^BXEOY*S);N3G=+/*Q9B?\ ,/0.*^5Q5AJU
MVLVY'7N(]*L.YD8=C*>#LTJYFLH-Z@3^+F1>EXB?RD\K^JS_ '6?CH@F<0*[
M!>_E1RH\W_4J_%6G4EBCNTVF;)P[E$@=I&82N.\JT>S1_=V>IQ\YTX5DI0K(
MV0L0]L3,*K1ROJO80TK(F[UI?'Q#@;$C0QW:)"RKWH\=2:2-M/2%D1=R^MQ!
MT%U!&?F.GK3FK,23\!TT5 3YH^YX6_LVV^JO&$G0,:45J1;&G<'>,<O7\2R<
M096M<K1=/+ H1RR+%'&$_5,NOA95\#1>;U>*=[$R"QCOG:\[S0G6,UVBE16[
M.S;S'C_*XQ=G'6((,?2IQ)94NJ\AT0"19N[:V_<69O/Y_6XZOR6'4KT\ZSB+
M:"J:RVE>#1=.SX:RE5]5>.N6ED6,'Y@ N0HU^:3Z^,]7QL@FN28ZTD"Q,"W,
M>!PFFGIW=W%W&1O'%FQ::6S$Q EDB**(W4=[(FC+IZC?O..FAT\ZSVZLE5<G
M- =5UAE9Y0S+V,R5O"_^C]7CI_)9_0841UVBED&L:;#( Q_=SD2-[/FXDSF(
MRE%.F9#"E*(K%+.SL@W,H9#N7=JVH?R\8^+.*+ S6+KO>T 75YX%=F4#L4AS
MO33RMQ8P&7MM<Q_2#SRP5VU,;NDX5=$/8BL[<V1?6V[?YB#*XE%3J*FFBKV*
M+,0[>4Q_M%_9,?L-[225[$;0SPL4EB<%65E.C*RGM!!_R5;)8F=Z]^NX:&1.
M_7NVD>LK>5E/FXH7LS1_AN3GB#V:>NNQO^-=P\6QO%'Y&\2_=%6&JGL(/<1P
M]RL]K%B4EGK563D@DZG8LB.4^RK;/95>)(,+782S:?,7)FWSR:=P9M%&T>RB
MJO%?K=I[(RU:,Q1P!H_ERIB>'M7E\S7;(W[7S<5K&5Y]>W54HMFHR)(T9[=C
M[TD#*I[5[/#Q/C,I72U1LKMFA?N([P01H58'M5E\2\&;YW("MNW?+"2+33V=
M_+W;?TO>X'3U>C$N&$;0FDPW(R.26W;M2Q8DLS'Q;N&G@MWZD#-J:L<D;*HU
M[D:2-GT^T7X7&86J*U8,7<ZEGD<C0O(Y[68Z?\E?#Q=R]N[DDLWYGL3)%+ $
M#2'4A0T#-M_"W%V7$V+<[7UC286WB< 1%B-O+CB]OT\29%/F,9:G8O.*;((G
M8]I8QNKA6/N;>'EQ<4DU^5=DM^RP>8IKKL7:%1%U]A?%Z^[A:6;K&41$M7L1
MG9-$Q&A*/]_TJVY&]9>!/9LWKT2G45I9(T0_><QHCG\EDXAJ58UAK5T6*"%!
MHJ(@"JJ@=RJHT'&6ZGJ3V7OYC?\ ,Q2M&85YD@D/+58U<>)?6=OYBOE<84I=
M1*HUD/9%9"C0++IW/IV+*/LON7;LDQV7J24[D1\44@TU'H93Y74^JR^'_(14
M,;6DMW)CMB@B4LQ/XNX#TL?"O$6:ZB$=O.#1Z]8:-#5/>#K^TF'M^1/V>[]9
M_-[Y/.48[<8UY4A\,L9/ICD71T_$?%ZW#V.EKBWX.]:5HB*<?>63LB?\KD\%
M<OBK5(#LYDL3",_9D V-^2WW 3$8RS>).FZ&)G0?:<#8OY3<1S]36DQ=7O:I
M 5FLD?5N&L,?VMTOV./E\)12NS#2:RWCGD^W(?$>WU?(OJK_ #A((U!["#P6
MNX+'V';75Y*L+-V^\5W<?_YO'_\ =T_S<!JF Q\#KW2)5A#_ )VW=_P\!5 5
M5&BJ.P #T#_U,6M9"U#3JJ0K3V)%BC!8Z*"SD+VGL'_H36LA:AIU5(5I[$BQ
M1@L=%!9R%[3V#_(2V;,J05X4:2::1@B(BC5F9FT"JH[2QXCM4YH[-690\,\+
M!XW4]Q5E)5A^#[B<4K4-HUI#!9$,BR<N5?-&^TG8X]*MXN"S$*JC5F/8 !Z3
MPES'6H;M2341V*\BRQMM)4Z.A*G0C0_=1&]:AJB>18(#/(L>^5_+&FXC<[>J
MH\7\M93,A.8U"M).D9[F9%)4'[Q;3BAU-U;)9RG4.4C2ZMWYF:(UUD^)$D"Q
MNJH$4KZ/-Y=O&8Z5Z5QM.:##K45[UMG"1<Q=TF\*X,C:'9$B[/$DC._&2FP4
M>*;&8FTM1JUV:0Y"\V]58U((R"BC5OB2*Z>MYOA<1].=)T*CWJU-<CF)\FTB
MPPQNH*PCE$.)FU':PV^[YF6+/4XJM"WG,A)CJ*QM*LR1.QCCY3:G?8U23=+\
M%5\R1[N.E.G>H*F(RV7S&2CJSHT<UFM\K" 6F G99'L)X':1O#N]7CJO&]/4
M:$E7IBK%9GO76D5%^$9I4(C;61W V0H.5XDDYDGE7CI6_6KTJF2ZF'Z_(RM%
M0K;4#.\CC1MAU\'B_.XOY+,KCUHPV'J4FH).O-:+SRAI7<-"VHY>WWMW&0Z:
MGFMKTUTWC_G<M0Q[.+%Z:5 Z0 1Z.ZF-ETC'F;[2[>KL[T?A[F)DQ8$4]/*L
M^SYQ041.69Y74\QD69=T;MX4]7PS]5=38JM5ISPU5PU"-V%B:Q."6YQ8LL,>
M@Y@31I$C\S,Z\9.EGABYZ%#&ME9<AA99)XH%0ZF"9V+1O-LU/PVV^'UO4PN2
M&(QT6+ZGO15,-$7F>U&C2 &2=051PT>XIL:/9YG\/FOX_%6*$>*Z?2.*W7E>
MR8FAM,K[RJ!1)<$8\ ;X,7B7VFXR4V"CQ38S$VEJ-6NS2'(7FWJK&I!&044:
MM\2173UO-\+BKTOTUBJ]N[8Q?S\OS;,BP2.^U>:P9?AH!XTV;W=XU5DXN9FZ
MD<E^A2:>:.($1-.L>I"@EF$9D][R\4.INK9+.4ZARD:75N_,S1&NLGQ(D@6-
MU5 BE?1YO+MXR]3I\8F.ETZW)L?Q.=Q8MR(=KQ4X8V#DH05YC;DXZ9Q.#Q$<
M^1SN.:]9I669&KED!CWN"HC2-N9S=R,TFWEQ[7XP73F/FQE;)5J(RMV(/:6K
M(Y4Q.EC9JYB20MRHU9MW@DD]55S-/IZA1LTNE*RV>H+=QY(A(W+,C0UMNNQ]
MJ/M:7>N[S>_T2M_%XVU>ZLOJ):5F%IJ\=17+<Q(V<DR)&8GWD[=WJ<=8U\%C
MZ#T.EDAD-VX90O9$7FC(C;XDK-X857E*NWXC^)..BZ^ ^7QUSJWDRD-+,DJ%
M0DK -& RUM&7FNIYK1^%5\7$6)ZI6C'33!R96W:IK,!\Q#(5D2,R.=8]@\*M
M'O9OS>(<SG*\-.2^S34JL*L"E5OU/,+.^Z1U\>Y=GA9?!Q__ $CK"8AJV&B6
MA7)] J1%YT![/VD2G[3<='S9'%T(L;U0_(5(VE^;) !:=4+%(X!N#*I:5V3Q
M-R]_&4S&.$!M4XC(GS)81]^G<H)9NWP)X=S>LO%UNI9X+5G*15XL8R-/);9;
MTG,E6RTITY@C<K''$-D>W9PO1^?HTZ6,Q>"3(0O6>226O!7 0K:=M$>30:OR
MT55]_=QAY*U3&/B<Q?6E%BHYWER\<98J;,J(3'$@'BV.OZ'Q.,YD4.V6"G-R
M6^J5U*1_ILO%+)6>D\K0SF*IM<GS=Z.:&I(^W1N3NF,;DHY*?!\J[_"W%+J>
M/#XVCDNI,D\,2QH:M-'E=T%JVVNYNR'=))N7?X?+QUI?R4V'.-P]>2E!<QBV
M&66W,!'&T4DKLCQ R#U?$S)ZO'1_1U[&U(,5E,?+/ L32M<B95:=I;&ND2B5
MRWPU7P[_ !2;EV<9R_)8H?\ Z_1M'%VJP>RRH:P8[J:Z)&SN[+SI91XE\B[=
MJ\6+D;J,E:/RF,5F51\Q*"%<EBJA(QK(S,=OAXZPQE2_'E:T$&.M&[7D$Z33
M&NQM.KAGUW3LWK<8>KATP,<>=EF6"FYLV;=2* ^)[8BDC5-Z@O%V+O7V?-QU
M#E,!C:,W3'3$IJWI[<DB3V)U(5Q7V>!1&[*?B+\1/(VYN/\ ^?X?(XJA9O9B
M$Y/(\^ R"HT,(E5JX9VY4@.]!(Q?CJ7+XO'8\X;IW)FDUJTTH::,.L6R)4;Q
M3;VYC.QC18F3P2-NXPF)QD./Q[9:J+7\1S9G6H';4?+AX=-LJZ EI#L\2^UQ
MTET]B9*=')YMEFL;)9^R6KI++$7C ;Y3M&]U^)*NY=JINW?.9KDM>K5C-?\
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M9:%J[&K2K8Z.)'5U)CBKC9O/,W;FW>7CIRWD>I9LG6Z:YJT:+5HX8Q&\>R(
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M2,F8,B'("_D[AK^*R-Y<Q[.;\,MX/B;Y/)Y>)ZMCJ:2#IJRT;RX84Z\C*T8
M^#9?XD6I7=Y6]?U6XP>:Q&:?#VL+"U6/_5X[6Z%QM8#F$!'*:KOVOQ)!,H>&
M52DB'N*L-"#^$<05,7U=8CZ6KV.?'A6JP.^TOS&B-H^/8[Z[MJ+X6;UO%QU!
M<QW4D^+I]2PK'DZ*5XY=[QH44\UF#"+Q'?&FQGW.O-V^7H^RM\_*=(UW@AJ<
MK]>[Q"+F%]_@T**^W8_VN.K*F2OO;;JNP\\\\<8B:%/V4:ZM)NY/JL?-[/%W
M!]0]12YS&V:GR$$/R\=7DP;-G8R%VDDV^N[<<X9B.W31#'%6CQU6K(1VA3/9
EBUFL,H/>[<9&)K?SUG)WYLA8L<OE>*;3PA=\G8NWVO\ W53_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Sep. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 15,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHAMPIONS ONCOLOGY, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1401755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 University Plaza, Suite 307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hackensack<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">808-8400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000771856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 15,  2025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="csbr-20250915.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://championsoncology.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="csbr-20250915.htm">csbr-20250915.htm</File>
    <File>csbr-20250915.xsd</File>
    <File>csbr-20250915_def.xml</File>
    <File>csbr-20250915_lab.xml</File>
    <File>csbr-20250915_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "csbr-20250915.htm": {
   "nsprefix": "csbr",
   "nsuri": "http://championsoncology.com/20250915",
   "dts": {
    "inline": {
     "local": [
      "csbr-20250915.htm"
     ]
    },
    "schema": {
     "local": [
      "csbr-20250915.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "csbr-20250915_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "csbr-20250915_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "csbr-20250915_pre.xml"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 22,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 19
   },
   "report": {
    "R1": {
     "role": "http://championsoncology.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "csbr-20250915.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "csbr-20250915.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://championsoncology.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000771856-25-000022-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000771856-25-000022-xbrl.zip
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M/2Y)N:R;JT(!>V5ZE&:,T'%_=N&X"@I0%?N)-E%GL(6Q(!5[J8V%P-W8Z+
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MI3Z;.3U;"]E>X$[AOX$<>M7_ U!+ P04    " #JA2];4E=3,'D"   3"
M$0   &-S8G(M,C R-3 Y,34N>'-DW57+;MLP$+S[*UB=2^OA1R(C=H F"%#
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M15H7[.WL+IMP_[;9OC^YD7Q@>\TM!C\!4$L#!!0    ( .J%+UO!A0TA]P(
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MQ[KX^W >%D6X;9C!"QW3/2J#O5?ER=$O4$L#!!0    ( .J%+UL45Q+/I D
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MP$%"@/D\ N:&G(D$QR$Q).PY^#AP:3UG+6B*5:T.?8FR<V<%4Q]C%ACM.AA
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M_^W/\MYR'>;X6$4P8]C>OQ' ?<Q9P;LW\&C@]K%7A[97^Z, >TW90F_B,C4
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MQ_W-NQ"M?QN7ZM79F^T[Z?J_#CQ[\S]02P,$%     @ ZH4O6W#ES%>N!@
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M/&(?^2W[(J=.\(,5\5",U#V1^!>'E\%[Z>-M.A9XA"\"GHW-;N)H?KF;B*$
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ME<: %NR6^SZ\ Q$K_- CBQ_!(@.EX9-BISI[&Q.O1<Z4LQAH8\'OF(.C 12
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MN;R!EZ@05,3_2E*A2/4#/"AF4QXK;74W PWK*-G&,<Y""2L A'*0@4%\01!
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M<:*U#V']8\*?.KD'9)='9)='H9SFJK\=%T 3!4.^?]GI[R4V>_0G.H@UM(K
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M<C@M:S<S,3(P,C5E>#DY,7AQ,3(V+FAT;5!+!08     !@ & )$!  !92P
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>csbr-20250915_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="csbr-20250915.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771856</identifier>
        </entity>
        <period>
            <startDate>2025-09-15</startDate>
            <endDate>2025-09-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-18">0000771856</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-19">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-09-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CHAMPIONS ONCOLOGY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-11504</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">52-1401755</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1 University Plaza, Suite 307</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Hackensack</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">07601</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">808-8400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-17">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
